{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,6,14]],"date-time":"2024-06-14T00:35:15Z","timestamp":1718325315635},"reference-count":26,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,6,13]]},"DOI":"10.7759\/cureus.62309","type":"journal-article","created":{"date-parts":[[2024,6,13]],"date-time":"2024-06-13T14:03:44Z","timestamp":1718287424000},"source":"Crossref","is-referenced-by-count":0,"title":["Comparison of Utero-Placental Perfusion Development From First to Second Trimester Between Low-Risk and High-Risk Pre-eclampsia Groups With Aspirin Prophylaxis"],"prefix":"10.7759","author":[{"given":"Jochen","family":"Ritgen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julia","family":"Roxin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marit","family":"Kolsch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arne","family":"Bergsch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jan","family":"Degenhardt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD004659","article-title":"Antiplatelet agents for preventing pre-eclampsia and its complications","author":"Duley L","year":"2004","unstructured":"Duley L, Henderson-Smart DJ, Knight M, King JF. Antiplatelet agents for preventing pre-eclampsia and its complications. Cochrane Database Syst Rev. 2004, CD004659. 10.1002\/14651858.CD004659","journal-title":"Cochrane Database Syst Rev"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1097\/AOG.0000000000002708","article-title":"ACOG committee opinion No. 743: low-dose aspirin use during pregnancy","volume":"132","year":"2018","unstructured":"ACOG committee opinion No. 743. low-dose aspirin use during pregnancy. Obstet Gynecol. 2018, 132:e44-52. 10.1097\/AOG.0000000000002708","journal-title":"Obstet Gynecol"},{"key":"ref3","unstructured":"National Institute for Health and Care Excellence. Hypertension in Pregnancy. Diagnosis and Management.. (2023). Accessed: Accessed June 2, 2024: https:\/\/www.nice.org.uk\/guidance\/ng133."},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1704559","article-title":"Aspirin versus placebo in pregnancies at high risk for preterm preeclampsia","volume":"377","author":"Rolnik DL","year":"2017","unstructured":"Rolnik DL, Wright D, Poon LC, et al.. Aspirin versus placebo in pregnancies at high risk for preterm preeclampsia. N Engl J Med. 2017, 377:613-22. 10.1056\/NEJMoa1704559","journal-title":"N Engl J Med"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198908103210604","article-title":"Effect of low-dose aspirin on fetal and maternal generation of thromboxane by platelets in women at risk for pregnancy-induced hypertension","volume":"321","author":"Benigni A","year":"1989","unstructured":"Benigni A, Gregorini G, Frusca T, et al.. Effect of low-dose aspirin on fetal and maternal generation of thromboxane by platelets in women at risk for pregnancy-induced hypertension. N Engl J Med. 1989, 321:357-62. 10.1056\/NEJM198908103210604","journal-title":"N Engl J Med"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1159\/000341712","article-title":"Combined screening for preeclampsia and small for gestational age at 11-13 weeks","volume":"33","author":"Poon LC","year":"2013","unstructured":"Poon LC, Syngelaki A, Akolekar R, Lai J, Nicolaides KH. Combined screening for preeclampsia and small for gestational age at 11-13 weeks. Fetal Diagn Ther. 2013, 33:16-27. 10.1159\/000341712","journal-title":"Fetal Diagn Ther"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2017.11.561","article-title":"Aspirin for the prevention of preterm and term preeclampsia: systematic review and metaanalysis","volume":"218","author":"Roberge S","year":"2018","unstructured":"Roberge S, Bujold E, Nicolaides KH. Aspirin for the prevention of preterm and term preeclampsia: systematic review and metaanalysis. Am J Obstet Gynecol. 2018, 218:287-293.e1. 10.1016\/j.ajog.2017.11.561","journal-title":"Am J Obstet Gynecol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2015.11.016","article-title":"Competing risks model in screening for preeclampsia by maternal factors and biomarkers at 19-24 weeks' gestation","volume":"214","author":"Gallo DM","year":"2016","unstructured":"Gallo DM, Wright D, Casanova C, Campanero M, Nicolaides KH. Competing risks model in screening for preeclampsia by maternal factors and biomarkers at 19-24 weeks' gestation. Am J Obstet Gynecol. 2016, 214:619.e1-619.e17. 10.1016\/j.ajog.2015.11.016","journal-title":"Am J Obstet Gynecol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2018.11.1087","article-title":"Predictive performance of the competing risk model in screening for preeclampsia","volume":"220","author":"Wright D","year":"2019","unstructured":"Wright D, Tan MY, O'Gorman N, Poon LC, Syngelaki A, Wright A, Nicolaides KH. Predictive performance of the competing risk model in screening for preeclampsia. Am J Obstet Gynecol. 2019, 220:199.e1-199.e13. 10.1016\/j.ajog.2018.11.1087","journal-title":"Am J Obstet Gynecol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1002\/uog.5315","article-title":"Reference ranges for uterine artery mean pulsatility index at 11-41 weeks of gestation","volume":"32","author":"G\u00f3mez O","year":"2008","unstructured":"G\u00f3mez O, Figueras F, Fern\u00e1ndez S, Bennasar M, Mart\u00ednez JM, Puerto B, Gratac\u00f3s E. Reference ranges for uterine artery mean pulsatility index at 11-41 weeks of gestation. Ultrasound Obstet Gynecol. 2008, 32:128-32. 10.1002\/uog.5315","journal-title":"Ultrasound Obstet Gynecol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1002\/uog.5402","article-title":"Uterine artery Doppler at 11 + 0 to 13 + 6 weeks and 21 + 0 to 24 + 6 weeks in the prediction of pre-eclampsia","volume":"32","author":"Plasencia W","year":"2008","unstructured":"Plasencia W, Maiz N, Poon L, Yu C, Nicolaides KH. Uterine artery Doppler at 11 + 0 to 13 + 6 weeks and 21 + 0 to 24 + 6 weeks in the prediction of pre-eclampsia. Ultrasound Obstet Gynecol. 2008, 32:138-46. 10.1002\/uog.5402","journal-title":"Ultrasound Obstet Gynecol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/s0029-7844(01)01474-0","article-title":"Individualized risk assessment for adverse pregnancy outcome by uterine artery Doppler at 23 weeks","volume":"98","author":"Lees C","year":"2001","unstructured":"Lees C, Parra M, Missfelder-Lobos H, Morgans RM A, Fletcher O, Nicolaides KH. Individualized risk assessment for adverse pregnancy outcome by uterine artery Doppler at 23 weeks. Obstet Gynecol. 2001, 98:369-73. 10.1016\/s0029-7844(01)01474-0","journal-title":"Obstet Gynecol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2011.10.878","article-title":"Prevalence, trends, and outcomes of chronic hypertension: a nationwide sample of delivery admissions","volume":"206","author":"Bateman BT","year":"2012","unstructured":"Bateman BT, Bansil P, Hernandez-Diaz S, Mhyre JM, Callaghan WM, Kuklina EV. Prevalence, trends, and outcomes of chronic hypertension: a nationwide sample of delivery admissions. Am J Obstet Gynecol. 2012, 206:134.e1-8. 10.1016\/j.ajog.2011.10.878","journal-title":"Am J Obstet Gynecol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1097\/AOG.0000000000002114","article-title":"Pregnancy-related mortality in the United States, 2011-2013","volume":"130","author":"Creanga AA","year":"2017","unstructured":"Creanga AA, Syverson C, Seed K, Callaghan WM. Pregnancy-related mortality in the United States, 2011-2013. Obstet Gynecol. 2017, 130:366-73. 10.1097\/AOG.0000000000002114","journal-title":"Obstet Gynecol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1002\/uog.17493","article-title":"Chronic hypertension and adverse pregnancy outcome: a cohort study","volume":"50","author":"Panaitescu AM","year":"2017","unstructured":"Panaitescu AM, Syngelaki A, Prodan N, Akolekar R, Nicolaides KH. Chronic hypertension and adverse pregnancy outcome: a cohort study. Ultrasound Obstet Gynecol. 2017, 50:228-35. 10.1002\/uog.17493","journal-title":"Ultrasound Obstet Gynecol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1111\/j.0001-6349.2005.00508","article-title":"Maternal complications in women with chronic hypertension: a population-based cohort study","volume":"84","author":"Zetterstr\u00f6m K","year":"2005","unstructured":"Zetterstr\u00f6m K, Lindeberg SN, Haglund B, Hanson U. Maternal complications in women with chronic hypertension: a population-based cohort study. Acta Obstet Gynecol Scand. 2005, 84:419-24. 10.1111\/j.0001-6349.2005.00508","journal-title":"Acta Obstet Gynecol Scand"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.107.107565","article-title":"Adverse perinatal outcomes and risk factors for preeclampsia in women with chronic hypertension: a prospective study","volume":"51","author":"Chappell LC","year":"2008","unstructured":"Chappell LC, Enye S, Seed P, Briley AL, Poston L, Shennan AH. Adverse perinatal outcomes and risk factors for preeclampsia in women with chronic hypertension: a prospective study. Hypertension. 2008, 51:1002-9. 10.1161\/HYPERTENSIONAHA.107.107565","journal-title":"Hypertension"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2019.06.031","article-title":"Blood pressure trajectory and category and risk of hypertensive disorders of pregnancy in nulliparous women","volume":"221","author":"Hauspurg A","year":"2019","unstructured":"Hauspurg A, Parry S, Mercer BM, et al.. Blood pressure trajectory and category and risk of hypertensive disorders of pregnancy in nulliparous women. Am J Obstet Gynecol. 2019, 221:277.e1-8. 10.1016\/j.ajog.2019.06.031","journal-title":"Am J Obstet Gynecol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejogrb.2023.03.011","article-title":"Is blood pressure 120-139\/80-89\u00a0mmHg before 20\u00a0weeks a risk factor for hypertensive disorders of pregnancy? A meta-analysis","volume":"284","author":"Sisti G","year":"2023","unstructured":"Sisti G, Fochesato C, Elkafrawi D, Marcus B, Schiattarella A. Is blood pressure 120-139\/80-89\u00a0mmHg before 20\u00a0weeks a risk factor for hypertensive disorders of pregnancy? A meta-analysis. Eur J Obstet Gynecol Reprod Biol. 2023, 284:66-75. 10.1016\/j.ejogrb.2023.03.011","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajogmf.2021.100376","article-title":"Defining the risk profile of women with stage 1 hypertension: a time to event analysis","volume":"3","author":"Sabol BA","year":"2021","unstructured":"Sabol BA, Porcelli B, Diveley E, et al.. Defining the risk profile of women with stage 1 hypertension: a time to event analysis. Am J Obstet Gynecol MFM. 2021, 3:100376. 10.1016\/j.ajogmf.2021.100376","journal-title":"Am J Obstet Gynecol MFM"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2017.07.038","article-title":"Aspirin for Evidence-Based Preeclampsia Prevention trial: effect of aspirin in prevention of preterm preeclampsia in subgroups of women according to their characteristics and medical and obstetrical history","volume":"217","author":"Poon LC","year":"2017","unstructured":"Poon LC, Wright D, Rolnik DL, et al.. Aspirin for Evidence-Based Preeclampsia Prevention trial: effect of aspirin in prevention of preterm preeclampsia in subgroups of women according to their characteristics and medical and obstetrical history. Am J Obstet Gynecol. 2017, 217:585.e1-5. 10.1016\/j.ajog.2017.07.038","journal-title":"Am J Obstet Gynecol"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1038\/sj.ki.5002175","article-title":"Uteroplacental ischemia results in proteinuric hypertension and elevated sFLT-1","volume":"71","author":"Makris A","year":"2007","unstructured":"Makris A, Thornton C, Thompson J, et al.. Uteroplacental ischemia results in proteinuric hypertension and elevated sFLT-1. Kidney Int. 2007, 71:977-84. 10.1038\/sj.ki.5002175","journal-title":"Kidney Int"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1067\/s0002-9378(03)00652-5","article-title":"A proinflammatory cytokine response is present in the fetal placental vasculature in placental insufficiency","volume":"189","author":"Wang X","year":"2003","unstructured":"Wang X, Athayde N, Trudinger B. A proinflammatory cytokine response is present in the fetal placental vasculature in placental insufficiency. Am J Obstet Gynecol. 2003, 189:1445-51. 10.1067\/s0002-9378(03)00652-5","journal-title":"Am J Obstet Gynecol"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1002\/uog.15819","article-title":"Uterine artery pulsatility index at 12, 22, 32 and 36 weeks' gestation in screening for pre-eclampsia","volume":"47","author":"O'Gorman N","year":"2016","unstructured":"O'Gorman N, Tampakoudis G, Wright A, Wright D, Nicolaides KH. Uterine artery pulsatility index at 12, 22, 32 and 36 weeks' gestation in screening for pre-eclampsia. Ultrasound Obstet Gynecol. 2016, 47:565-72. 10.1002\/uog.15819","journal-title":"Ultrasound Obstet Gynecol"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1097\/AOG.0000000000003901","article-title":"Maternal obesity and the risk of early-onset and late-onset hypertensive disorders of pregnancy","volume":"136","author":"Bicocca MJ","year":"2020","unstructured":"Bicocca MJ, Mendez-Figueroa H, Chauhan SP, Sibai BM. Maternal obesity and the risk of early-onset and late-onset hypertensive disorders of pregnancy. Obstet Gynecol. 2020, 136:118-27. 10.1097\/AOG.0000000000003901","journal-title":"Obstet Gynecol"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.2174\/1570161118666200616144512","article-title":"Effects of maternal obesity and gestational diabetes mellitus on the placenta: current knowledge and targets for therapeutic interventions","volume":"19","author":"Bedell S","year":"2021","unstructured":"Bedell S, Hutson J, de Vrijer B, Eastabrook G. Effects of maternal obesity and gestational diabetes mellitus on the placenta: current knowledge and targets for therapeutic interventions. Curr Vasc Pharmacol. 2021, 19:176-92. 10.2174\/1570161118666200616144512","journal-title":"Curr Vasc Pharmacol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/257325-comparison-of-utero-placental-perfusion-development-from-first-to-second-trimester-between-low-risk-and-high-risk-pre-eclampsia-groups-with-aspirin-prophylaxis","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,13]],"date-time":"2024-06-13T14:03:48Z","timestamp":1718287428000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/257325-comparison-of-utero-placental-perfusion-development-from-first-to-second-trimester-between-low-risk-and-high-risk-pre-eclampsia-groups-with-aspirin-prophylaxis"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,13]]},"references-count":26,"URL":"https:\/\/doi.org\/10.7759\/cureus.62309","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6,13]]}}}